cyc 202 has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grandis, JR; Lu, Y; Stehle, C; Steinman, RA; Wentzel, A | 1 |
| Kiyota, A; Matsumura, T; Mihara, M; Shintani, S; Wong, DT | 1 |
2 other study(ies) available for cyc 202 and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2.
Topics: 3T3 Cells; Animals; Carcinoma, Squamous Cell; CDC2-CDC28 Kinases; Cell Communication; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA-Binding Proteins; Enzyme Inhibitors; ErbB Receptors; Fibroblasts; Head and Neck Neoplasms; Humans; Mice; Mice, Knockout; Phosphorylation; Protein Serine-Threonine Kinases; Purines; rac1 GTP-Binding Protein; Roscovitine; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Transforming Growth Factor alpha; Tumor Cells, Cultured; Up-Regulation | 2003 |
Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells.
Topics: Apoptosis; bcl-X Protein; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Gene Expression; Head and Neck Neoplasms; Humans; Proto-Oncogene Proteins c-bcl-2; Purines; Roscovitine; Tumor Cells, Cultured | 2002 |